Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

PharmAthene (PIP)

Add to Watchlists
Create an Alert
1.45 +0.04  +2.84% AMEX Apr 23, 5:00PM BATS Real time Currency in USD

PharmAthene Research and Development Expense (Quarterly):

4.098M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

PharmAthene Research and Development Expense (Quarterly) Chart

Export Data
Save Image

PharmAthene Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 4.098M
Sept. 30, 2013 2.556M
June 30, 2013 3.402M
March 31, 2013 5.234M
Dec. 31, 2012 4.747M
Sept. 30, 2012 5.139M
June 30, 2012 4.919M
March 31, 2012 4.705M
Dec. 31, 2011 4.531M
Sept. 30, 2011 4.884M
June 30, 2011 5.984M
March 31, 2011 5.820M
Dec. 31, 2010 3.811M
Sept. 30, 2010 6.172M
June 30, 2010 5.940M
March 31, 2010 4.952M
Dec. 31, 2009 6.291M
Sept. 30, 2009 7.884M
June 30, 2009 10.23M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for

PIP Research and Development Expense (Quarterly) Benchmarks

Grifols 45.39M
Siga Technologies 2.819M
Advanced Proteome Therpt

PIP Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 2.556M Sep 2013
Maximum 10.23M Jun 2009
Average 5.331M

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.